Balancing protective immunity and chronic sequelae by resident CD8 T cells

通过常驻 CD8 T 细胞平衡保护性免疫和慢性后遗症

基本信息

  • 批准号:
    9981307
  • 负责人:
  • 金额:
    $ 56.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-02-14 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

Summary/Abstract Tissue-resident memory T cells (TRM) that park within the non-lymphoid tissue provide superior immunity against a variety of pathogens including influenza virus infection. The mechanisms regulating CD8 TRM maintenance, heterogeneity, protective and pathological functions are incompletely understood. Our recent data have identified a novel protective CD8 TRM population that co-exhibits both exhausted and conventional memory CD8 T cell features following acute influenza infection. Unlike the conventional circulating memory CD8 T cells that are maintained in a MHC-I independent way, the survival and maintenance of these PD-1hi TRM cells require persistent MHC-I and TCR signaling. Based on these prelim data, we propose to further elucidate the underlying mechanisms by which these PD-1hi TRM are maintained in the lung. We hypothesize the intrinsic CD28 and PD-1 signaling, specifically in lung-resident CD8 T cells, balances the maintenance, protective function and fibrogenic activities of these PD-1hi TRM following influenza virus infection (Aim 1). Furthermore, we will test the hypothesis that the expression of the transcription factor Klf10 in CD8 T cells is vital for the maintenance and the function of these PD-1hi TRM (Aim 2). In addition, we will determine whether it is possible to uncouple the pathogenic activities from the protective function of TRM, so we may specifically provoke the protective function, but not the pathogenic activities of TRM for future vaccine design and/or immunotherapies (Aim 3). Relevance statement Each year, influenza virus infects 5–10% of adults and 20–30% of children, killing as many as 500,000 people globally. In addition to the acute morbidity and mortality, it is increasingly appreciated that influenza virus infection could lead to the development of chronic lung conditions including pulmonary fibrotic responses. Currently, little is known about the etiology of the development of chronic lung sequelae following influenza virus infection. The successful completion of this study will provide insights for developing interventions to promote the complete recovery of the tissue while minimizing the development of chronic lung conditions following acute respiratory viral infections. Furthermore, understanding the cellular and molecular mechanisms regulating the maintenance of lung protective TRM responses following influenza infection and/or immunization may aid the design of future influenza therapeutics and influenza vaccines.
摘要/摘要 驻留在非淋巴组织内的组织记忆T细胞(TRM)提供了上级免疫力 针对包括流感病毒感染在内的多种病原体。调节CD 8 TRM的机制 维持、异质性、保护和病理功能尚未完全了解。我们最近 数据已经确定了一种新的保护性CD 8 TRM群体,其同时表现出耗竭和 急性流感感染后的常规记忆性CD 8 T细胞特征。不像常规 以MHC-I非依赖性方式维持的循环记忆CD 8 T细胞, 这些PD-1hi TRM细胞的维持需要持续的MHC-I和TCR信号传导。根据这些初步的 数据,我们建议进一步阐明这些PD-1hi TRM维持的潜在机制, 肺我们假设固有的CD 28和PD-1信号传导,特别是在肺部驻留的CD 8 T细胞中, 平衡流感后这些PD-1hi TRM的维持、保护功能和纤维化活性 病毒感染(目的1)。此外,我们还将检验转录因子的表达 CD 8 T细胞中的Klf 10对于这些PD-1hi TRM的维持和功能至关重要(目的2)。另外我们 将决定是否有可能将致病活动与TRM的保护功能分开, 我们可以特异性地激发TRM的保护性功能,而不是致病性活性,用于未来的疫苗 设计和/或免疫疗法(目标3)。 相关性说明 每年,流感病毒感染5-10%的成年人和20-30%的儿童,造成多达50万人死亡 在全球除了急性发病率和死亡率之外,越来越多的人认识到,流感病毒 感染可导致包括肺纤维化反应的慢性肺病的发展。 目前,对流感后慢性肺部后遗症的病因学知之甚少 病毒感染。这项研究的成功完成将为制定干预措施提供见解, 促进组织的完全恢复,同时最大限度地减少慢性肺部疾病的发展 急性呼吸道病毒感染后。此外,了解细胞和分子机制 调节流感感染和/或免疫后肺保护性TRM应答的维持 可能有助于设计未来的流感治疗剂和流感疫苗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jie Sun其他文献

Jie Sun的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jie Sun', 18)}}的其他基金

Uncover mechanisms underlying the development of chronic lung sequelae post COVID-19
揭示 COVID-19 后慢性肺部后遗症发生的机制
  • 批准号:
    10734747
  • 财政年份:
    2023
  • 资助金额:
    $ 56.5万
  • 项目类别:
Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma
哮喘儿童恢复期和疫苗诱导的 SARS-CoV-2 粘膜特异性免疫以及值得关注的变体的决定因素
  • 批准号:
    10638521
  • 财政年份:
    2023
  • 资助金额:
    $ 56.5万
  • 项目类别:
Modeling severe respiratory syncytial virus pathogenesis in bronchopulmonarydysplasia
支气管肺发育不良中严重呼吸道合胞病毒发病机制的建模
  • 批准号:
    10515456
  • 财政年份:
    2022
  • 资助金额:
    $ 56.5万
  • 项目类别:
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection
组织驻留辅助 T 细胞在针对流感感染的粘膜免疫中的作用
  • 批准号:
    10605297
  • 财政年份:
    2022
  • 资助金额:
    $ 56.5万
  • 项目类别:
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection
组织驻留辅助 T 细胞在针对流感感染的粘膜免疫中的作用
  • 批准号:
    10393621
  • 财政年份:
    2022
  • 资助金额:
    $ 56.5万
  • 项目类别:
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection
组织驻留辅助 T 细胞在针对流感感染的粘膜免疫中的作用
  • 批准号:
    10515543
  • 财政年份:
    2022
  • 资助金额:
    $ 56.5万
  • 项目类别:
COVID-19 competitive revision: BALANCING PROTECTIVE IMMUNITY AND CHRONIC SEQUELAE BY RESIDENT CD8 T CELLS
COVID-19 竞争性修订:平衡驻留 CD8 T 细胞的保护性免疫和慢性后遗症
  • 批准号:
    10224990
  • 财政年份:
    2020
  • 资助金额:
    $ 56.5万
  • 项目类别:
Modeling severe respiratory syncytial virus pathogenesis in bronchopulmonary dysplasia
支气管肺发育不良中严重呼吸道合胞病毒发病机制的建模
  • 批准号:
    9981352
  • 财政年份:
    2020
  • 资助金额:
    $ 56.5万
  • 项目类别:
Elucidating the roles of alveolar macrophage inflammation and self renewal duringinfluenza infection
阐明流感感染期间肺泡巨噬细胞炎症和自我更新的作用
  • 批准号:
    10515526
  • 财政年份:
    2020
  • 资助金额:
    $ 56.5万
  • 项目类别:
Elucidating the roles of alveolar macrophage inflammation and self renewal duringinfluenza infection
阐明流感感染期间肺泡巨噬细胞炎症和自我更新的作用
  • 批准号:
    10652322
  • 财政年份:
    2020
  • 资助金额:
    $ 56.5万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了